The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
New trends for metal complexes with anticancer activity
Open accessAbstract
Summary Medicinal inorganic chemistry can exploit the unique properties of metal ions for the design of new drugs. This has, for instance, led to the clinical application of chemotherapeutic agents for cancer treatment, such as cisplatin. The use of cisplatin is, however, severely limited by its toxic side effects. This has spurred chemists to employ different strategies in the development of new metal-based anticancer agents with different mechanisms of action. Recent trends in the field are discussed in this review. These include the more selected delivery and/or activation of cisplatin-related prodrugs and the discovery of new non-covalent interactions with the classical target, DNA. The use of the metal as scaffold rather than reactive centre and the departure from the cisplatin paradigm of activity towards a more targeted, cancer cell-specific approach, a major trend, are discussed as well. All this, together with the observation that some of the new drugs are organometallic complexes, illustrates that exciting times lie ahead for those interested in ‘metals in medicine’.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Direct Cellular Responses to Platinum-Induced DNA Damage
Jung, Y., & Lippard, S. J. (2007) · Chemical Reviews · doi:10.1021/cr068207j · Cited by 1,391
In Vitro and in Vivo Evaluation of Ruthenium(II)−Arene PTA Complexes
Scolaro, C., Bergamo, A., Brescacín, L., Delfino, R., Cocchietto, M., Laurenczy, G., Geldbach, T. J., Sava, G., & Dyson, P. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050015d · Cited by 908
Guo, Z., & Sadler, P. J. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990601)38:11<1512::aid-anie1512>3.0.co;2-y · Cited by 834
Self-citationMetal-based antitumour drugs in the post genomic era
Dyson, P. J., & Sava, G. (2006) · Dalton Transactions · doi:10.1039/b601840h · Cited by 771
Classical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted Chemotherapy
Ang, W. H., & Dyson, P. J. (2006) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200600723 · Cited by 713
Feazell, R. P., Nakayama-Ratchford, N., Dai, H., & Lippard, S. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073231f · Cited by 616
Timerbaev, A. R., Hartinger, C. G., Aleksenko, S. S., & Keppler, B. K. (2006) · Chemical Reviews · doi:10.1021/cr040704h · Cited by 614
Medicinal Inorganic Chemistry: Introduction
Orvig, C., & Abrams, M. J. (1999) · Chemical Reviews · doi:10.1021/cr980419w · Cited by 532
Basis for Design and Development of Platinum(IV) Anticancer Complexes
Hall, M. D., Mellor, H. R., Callaghan, R., & Hambley, T. W. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070280u · Cited by 458
Habtemariam, A., Melchart, M., Fernández, R., Parsons, S., Oswald, I. D. H., Parkin, A., Fabbiani, F. P. A., Davidson, J. E., Dawson, A., Aird, R. E., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060596m · Cited by 456
Self-citationTargeting the mitochondrial cell death pathway with gold compounds
Barnard, P. J., & Berners-Price, S. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2007.04.006 · Cited by 417
Supramolecular DNA recognition
Hannon, M. J. (2006) · Chemical Society Reviews · doi:10.1039/b606046n · Cited by 391
Reed, J. E., Arnal, A. A., Neidle, S., & Vilar, R. (2006) · Journal of the American Chemical Society · doi:10.1021/ja058509n · Cited by 338
On the potential of thioredoxin reductase inhibitors for cancer therapy
Urig, S., & Becker, K. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.09.004 · Cited by 337
Developing new metal-based therapeutics: challenges and opportunities
Hambley, T. W. (2007) · Dalton Transactions · doi:10.1039/b706075k · Cited by 337
Milacic, V., Chen, D., Ronconi, L., Landis-Piwowar, K. R., Fregona, D., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3017 · Cited by 317
Ang, W. H., Khalaila, I., Allardyce, C. S., Juillerat-Jeanneret, L., & Dyson, P. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0432618 · Cited by 314
MacDiarmid, J. A., Mugridge, N. B., Weiss, J. C., Phillips, L., Burn, A. L., Paulin, R. P., Haasdyk, J. E., Dickson, K.-A., Brahmbhatt, V. N., Pattison, S. T., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.03.012 · Cited by 307
Molecular Recognition of a Three‐Way DNA Junction by a Metallosupramolecular Helicate
Oleksy, A., Blanco, A. G., Boer, R., Usón, I., Aymamí, J., Rodger, A., Hannon, M. J., & Coll, M. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503822 · Cited by 303
A potent cytotoxic photoactivated platinum complex
Mackay, F. S., Woods, J. A., Heringová, P., Kašpárková, J., Pizarro, A. M., Moggach, S. A., Parsons, S., Brabec, V., & Sadler, P. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707742105 · Cited by 303
Self-citationMetal complexes in medicinal chemistry: new vistas and challenges in drug design
Thompson, K. H., & Orvig, C. (2006) · Dalton Trans. · doi:10.1039/b513476e · Cited by 298
Targeting platinum anti-tumour drugs: Overview of strategies employed to reduce systemic toxicity
Zutphen, S. V., & Reedijk, J. (2005) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2005.03.005 · Cited by 295
Ruthenium complexes can target determinants of tumour malignancy
Bergamo, A., & Sava, G. (2007) · Dalton Transactions · doi:10.1039/b617769g · Cited by 291
Barnes, K. R., Kutikov, A., & Lippard, S. J. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.03.024 · Cited by 263
Ruthenium Half‐Sandwich Complexes Bound to Protein Kinase Pim‐1
Debreczeni, J. É., Bullock, A. N., Atilla, G. E., Williams, D. S., Bregman, H., Knapp, S., & Meggers, E. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503468 · Cited by 234
Smalley, K. S. M., Contractor, R., Haass, N. K., Kulp, A. N., Atilla-Gokcumen, G. E., Williams, D. S., Bregman, H., Flaherty, K. T., Soengas, M. S., Meggers, E., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1538 · Cited by 230
Encapsulation of platinum anticancer drugs by apoferritin
Yang, Z., Wang, X., Diao, H., Zhang, J., Li, H., Sun, H., & Guo, Z. (2007) · Chemical Communications · doi:10.1039/b705326f · Cited by 225
Ott, I., Schmidt, K., Kircher, B., Schumacher, P., Wiglenda, T., & Gust, R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049326z · Cited by 207
Undressing of Phosphine Gold( I ) Complexes as Irreversible Inhibitors of Human Disulfide Reductases
Urig, S., Fritz‐Wolf, K., Réau, R., Herold‐Mende, C., Tóth, K., Davioud‐Charvet, E., & Becker, K. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502756 · Cited by 206
A G-Quadruplex Ligand with 10000-Fold Selectivity over Duplex DNA
Dixon, I. M., Lopez, F., Tejera, A. M., Estève, J.-P., Blasco, M. A., Pratviel, G., & Meunier, B. (2007) · Journal of the American Chemical Society · doi:10.1021/ja065591t · Cited by 204
New Principles in Medicinal Organometallic Chemistry
Schatzschneider, U., & Metzler‐Nolte, N. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200504604 · Cited by 194
A Third Mode of DNA Binding: Phosphate Clamps by a Polynuclear Platinum Complex
Komeda, S., Moulaei, T., Woods, K. K., Chikuma, M., Farrell, N. P., & Williams, L. D. (2006) · Journal of the American Chemical Society · doi:10.1021/ja062851y · Cited by 178
Some uses of transition metal complexes as anti-cancer and anti-HIV agents
Wai-Yin Sun, R., Ma, D.-L., Wong, E. L.-M., & Che, C.-M. (2007) · Dalton Transactions · doi:10.1039/b705079h · Cited by 174
Bregman, H. S., Carroll, P. J., & Meggers, E. (2005) · Journal of the American Chemical Society · doi:10.1021/ja055523r · Cited by 165
Failes, T. W., Cullinane, C. M., Diakos, C. I., Yamamoto, N., Lyons, J. G., & Hambley, T. W. (2006) · Chemistry - A European Journal · doi:10.1002/chem.200601137 · Cited by 143
Diversity in Guanine‐Selective DNA Binding Modes for an Organometallic Ruthenium Arene Complex
Liu, H., Berners‐Price, S. J., Wang, F., Parkinson, J. A., Xu, J., Bella, J., & Sadler, P. J. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602873 · Cited by 142
Self-citationCalderone, V., Casini, A., Mangani, S., Luigi Messori, A., & Orioli, P. L. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502599 · Cited by 109
Wang, Y., He, Q., Che, C., & Chiu, J. (2005) · PROTEOMICS · doi:10.1002/pmic.200402027 · Cited by 87
cis -[Rh 2 (μ-O 2 CCH 3 ) 2 (CH 3 CN) 6 ] 2+ as a Photoactivated Cisplatin Analog
Lutterman, D. A., Fu, P. K. ‐., & Turró, C. (2005) · Journal of the American Chemical Society · doi:10.1021/ja057620q · Cited by 84
Iron‐Containing Nucleoside Analogues with Pronounced Apoptosis‐Inducing Activity
Schlawe, D., Majdalani, A., Velcicky, J., Heßler, E., Wieder, T., Prokop, A., & Schmalz, H. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200353132 · Cited by 81
Transplatin Is Cytotoxic When Photoactivated: Enhanced Formation of DNA Cross-Links
Heringová, P., Woods, J. A., Mackay, F. S., Kašpárková, J., Sadler, P. J., & Brabec, V. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0606692 · Cited by 74
Self-citation
Cited by
Advances in Copper Complexes as Anticancer Agents
Santini, C., Pellei, M., Gandin, V., Porchia, M., Tisato, F., & Marzano, C. (2014) · Chemical Reviews · doi:10.1021/cr400135x · Cited by 1,790
Light-Emitting Self-Assembled Materials Based on d8 and d10 Transition Metal Complexes
Yam, V. W.-W., Au, V. K.-M., & Leung, S. Y.-L. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00074 · Cited by 1,661
Metal complexes in cancer therapy – an update from drug design perspective
Ndagi, U., Mhlongo, N., & Soliman, M. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s119488 · Cited by 935
On the medicinal chemistry of gold complexes as anticancer drugs
Ott, I. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.019 · Cited by 825
The Medicinal Applications of Imidazolium Carbene−Metal Complexes
Hindi, K. M., Panzner, M. J., Tessier, C. A., Cannon, C. L., & Youngs, W. J. (2009) · Chemical Reviews · doi:10.1021/cr800500u · Cited by 776
Metadata
- Authors
- Bruijnincx, P. C., & Sadler, P. J.
- Venue
- Current Opinion in Chemical Biology
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 12
- Issue
- 2
- Pages
- 197-206
- ISSN
- 1367-5931 (ISSN-L)
- OpenAlex
- W2001976945
- Cited by
- 1,306
- References
- 41
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.